Open AccessDisseminated medullary thyroid carcinoma. Optimal approach to treatment
Author(s) -
И. С. Романов,
Е. Л. Дронова,
Е. Е. Станякина
Publication year - 2019
Publication title -
opuholi golovy i šei
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.14
H-Index - 1
eISSN - 2411-4634
pISSN - 2222-1468
DOI - 10.17650/2222-1468-2018-8-4-21-25
Subject(s) - medullary cavity , medical prescription , medicine , thyroid carcinoma , medullary carcinoma , thyroid , tyrosine kinase , thyroid cancer , cancer , oncology , medullary thyroid cancer , pathology , intensive care medicine , pharmacology , receptor
Medullary thyroid cancer is a rare tumor. Due to variability of its biological behavior, treatment of this tumor often is a complicated problem. Clinicians have difficulties with determination of indications for prescription of tyrosine kinase inhibitors. Prescription should be based on scru-tinous monitoring of the patients and consideration of all factors: level of tumor markers, patient’s state, and data form visual examinations.